176 related articles for article (PubMed ID: 35312681)
1. Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach.
Rowaiye AB; Ogugua AJ; Ibeanu G; Bur D; Asala MT; Ogbeide OB; Abraham EO; Usman HB
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0009799. PubMed ID: 35312681
[TBL] [Abstract][Full Text] [Related]
2. Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.
Ojo KK; Ranade RM; Zhang Z; Dranow DM; Myers JB; Choi R; Nakazawa Hewitt S; Edwards TE; Davies DR; Lorimer D; Boyle SM; Barrett LK; Buckner FS; Fan E; Van Voorhis WC
PLoS One; 2016; 11(8):e0160350. PubMed ID: 27500735
[TBL] [Abstract][Full Text] [Related]
3. RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2'-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION.
Rowaiye AB; Oli AN; Onuh OA; Emeter NW; Bur D; Obideyi OA; Dayisi OC; Akpa JN; Birah L; Omaka EE; Iseghohi FO; Otitoju AP; Uzor PF; Okoyeh JN
Afr J Infect Dis; 2022; 16(2):80-96. PubMed ID: 35582066
[TBL] [Abstract][Full Text] [Related]
4. High Throughput Virtual Screening to Identify Novel natural product Inhibitors for MethionyltRNA-Synthetase of Brucella melitensis.
Kumari M; Chandra S; Tiwari N; Subbarao N
Bioinformation; 2017; 13(1):8-16. PubMed ID: 28479744
[TBL] [Abstract][Full Text] [Related]
5. Camptothecin shows better promise than Curcumin in the inhibition of the Human Telomerase: A computational study.
Rowaiye AB; Mendes YJT; Olofinsae SA; Oche JB; Oladipo OH; Okpalefe OA; Ogidigo JO
Heliyon; 2021 Aug; 7(8):e07742. PubMed ID: 34485722
[TBL] [Abstract][Full Text] [Related]
6. Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M.
Pradeepkiran JA; Kumar KK; Kumar YN; Bhaskar M
Drug Des Devel Ther; 2015; 9():1897-912. PubMed ID: 25848225
[TBL] [Abstract][Full Text] [Related]
7. Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M.
Pradeepkiran JA; Sainath SB; Kumar KK; Bhaskar M
Drug Des Devel Ther; 2015; 9():1691-706. PubMed ID: 25834405
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide Core Proteome Analysis of Brucella melitensis Strains for Potential Drug Target Prediction.
Rahman N; Shah M; Muhammad I; Khan H; Imran M
Mini Rev Med Chem; 2021; 21(18):2778-2787. PubMed ID: 32634082
[TBL] [Abstract][Full Text] [Related]
9. Molecular Docking and
Muhammad I; Niaz S; Gul E Nayab ; Hussain A; Ahmad S; Rahman N; Khan H; Ali A
Curr Comput Aided Drug Des; 2021; 17(7):946-956. PubMed ID: 32532195
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-based virtual screening: the discovery of novel methionyl-tRNA synthetase inhibitors.
Kim SY; Lee YS; Kang T; Kim S; Lee J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4898-907. PubMed ID: 16824759
[TBL] [Abstract][Full Text] [Related]
11. Identification of Phosphoribosyl-AMP cyclohydrolase, as drug target and its inhibitors in Brucella melitensis bv. 1 16M using metabolic pathway analysis.
Gupta M; Prasad Y; Sharma SK; Jain CK
J Biomol Struct Dyn; 2017 Feb; 35(2):287-299. PubMed ID: 26725317
[TBL] [Abstract][Full Text] [Related]
12. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.
Motamedi H; Darabpour E; Gholipour M; Seyyed Nejad SM
J Zhejiang Univ Sci B; 2010 Jul; 11(7):506-11. PubMed ID: 20593515
[TBL] [Abstract][Full Text] [Related]
13. 2-[2-Substituted-3-(3,4-dichlorobenzylamino)propylamino]-1H-quinolin-4-ones as Staphylococcus aureus methionyl-tRNA synthetase inhibitors.
Farhanullah ; Kang T; Yoon EJ; Choi EC; Kim S; Lee J
Eur J Med Chem; 2009 Jan; 44(1):239-50. PubMed ID: 18403059
[TBL] [Abstract][Full Text] [Related]
14. Investigation of bioisosteric effects on the interaction of substrates/ inhibitors with the methionyl-tRNA synthetase from Escherichia coli.
Vaughan MD; Sampson PB; Daub E; Honek JF
Med Chem; 2005 May; 1(3):227-37. PubMed ID: 16787318
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
Bharatham N; Bharatham K; Lee KW
J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
[TBL] [Abstract][Full Text] [Related]
16. Novel hybrid virtual screening protocol based on molecular docking and structure-based pharmacophore for discovery of methionyl-tRNA synthetase inhibitors as antibacterial agents.
Liu C; He G; Jiang Q; Han B; Peng C
Int J Mol Sci; 2013 Jul; 14(7):14225-39. PubMed ID: 23839093
[TBL] [Abstract][Full Text] [Related]
17. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel inhibitors of methionyl-tRNA synthetase (MetRS) by virtual screening.
Finn J; Stidham M; Hilgers M; G C K
Bioorg Med Chem Lett; 2008 Jul; 18(14):3932-7. PubMed ID: 18590962
[TBL] [Abstract][Full Text] [Related]
19. Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections.
Faghih O; Zhang Z; Ranade RM; Gillespie JR; Creason SA; Huang W; Shibata S; Barros-Álvarez X; Verlinde CLMJ; Hol WGJ; Fan E; Buckner FS
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848016
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
